Cota Healthcare Stock
Cota builds solutions for healthcare to analyze, visualize, report, and manage real-world evidence and deliver precision medicine.
Sign up today and learn more about Cota Healthcare Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cota Healthcare Stock
Cota empowers healthcare professionals with data and technology solutions to deliver value-based precision medicine. Cota is a technology platform that enables providers, payers, and life science companies to make value-based decisions with real-world evidence about diagnosing and treating complex diseases. Beginning with oncology and now expanding into behavioral health and chronic medical conditions, Cota enriches raw medical records to create research-grade clinical data, classifies each patient and their disease in a uniquely powerful way using a patented methodology, and combines this cohorted patient data with cost data. Use of Cota enables providers to improve individual patient clinical outcomes and lower the total cost of care of the population served. Cota also enables life sciences companies to accelerate clinical development, and academics and advocacy organizations to accelerate research, all via an easy-to-use web-based interface.
Investors
Hackensack Meridian Health
Memorial Sloan - Kettering Cancer Center
IQVIA
EW Healthcare Partners
Horizon Blue Cross Blue Shield of New Jersey
Funding History
September 2014 | $7.0M |
---|---|
May 2016 | $0 |
December 2016 | $18.0M |
February 2018 | $40.0M |
Management
Chief Executive Officer
Michael Doyle
Chief Medical Officer
Andrew Norden
Chief Technology Officer
Bernard Chien
Chief Legal Officer
Elizabeth Rushforth
Press
cancerletter - Nov, 10 2020
Study of NSCLC, melanoma outcomes points to surrogacy between real-world endpoints and clinical trial endpointsprnewswire - Nov, 10 2020
Varian Medical Systems Invests in COTA, Inc. to Help Drive Faster, More Accurate Data-Driven Cancer Carenews-medical - Nov, 10 2020
Researchers identify drug that improves survival in critically ill COVID-19 patientsworldpharmanews - Nov, 10 2020
Observational study identifies drug that improves survival in sickest COVID-19 patients